VivoSim Labs VIVS
NASDAQ VIVS
$0.16 +0.00 (+1.34%)
As of: Oct 19, 2026 · 3:56 PM EDT

VivoSim Labs (VIVS) Accumulated Expenses (2011 - 2026)

Updated

VivoSim Labs (VIVS) recorded Accumulated Expenses of $738,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 1.5% from $727,000 a year earlier but down 24.8% from the prior quarter.

Analysis

VivoSim Labs (VIVS) Accumulated Expenses (2011 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), VivoSim Labs reported Accumulated Expenses of $981,000, down 20.0% from FY2025.

  • Annual Accumulated Expenses has a five-year compound annual growth rate of 17.4% (FY2021 to FY2026).
  • Across earlier fiscal years, Accumulated Expenses came in at $1.23 million in FY2025 (+68.6%), $727,000 in FY2024 (-74.5%), $2.85 million in FY2023 (+482.4%) and $489,000 in FY2022 (+11.1%).
  • Quarterly Accumulated Expenses has ranged from $404,000 in fiscal Q1 2025 to $2.85 million in fiscal Q4 2023 over the past five years.
  • On a year-over-year basis, Accumulated Expenses rose in five of the last eight quarters, with growth averaging 21.3%.
  • Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 482.4% in fiscal Q4 2023, against a decline of 74.5% in fiscal Q4 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $981,000 (Q4 2026), $818,000 (Q3 2026) and $771,000 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.17 Bn 35.87 Bn 1.44 Bn
2 Medpace Holdings 17.45 Bn 15.51 Bn 201.64 Mn
3 Charles River Laboratories International 14.37 Bn 13.56 Bn 363.37 Mn
4 Icon 13.16 Bn 10.27 Bn 479.29 Mn
5 Fortrea Holdings 2.12 Bn 1.50 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 625.60 Mn -136.48 Mn 18.44 Mn
7 Evotec SE 506.10 Mn -1.10 Bn -
8 Champions Oncology 65.60 Mn 40.68 Mn 7.70 Mn
9 MindWalk Holdings 61.22 Mn 24.88 Mn 1.61 Mn
10 VivoSim Labs 832,550.47 -16.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 738,000.00
Mar 31, 2026 981,000.00
Dec 31, 2025 818,000.00
Sep 30, 2025 771,000.00
Jun 30, 2025 727,000.00
Mar 31, 2025 1.23 Mn
Dec 31, 2024 1.02 Mn
Sep 30, 2024 879,000.00
Jun 30, 2024 404,000.00
Mar 31, 2024 727,000.00
Dec 31, 2023 727,000.00
Sep 30, 2023 666,000.00
Jun 30, 2023 787,000.00
Mar 31, 2023 2.85 Mn
Dec 31, 2022 646,000.00
Sep 30, 2022 462,000.00
Jun 30, 2022 670,000.00
Mar 31, 2022 489,000.00
Dec 31, 2021 926,000.00
Sep 30, 2021 717,000.00
API Access

VivoSim Labs Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=VIVS&period=max&api_key=YOUR_API_KEY